Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders after COVID-19: A Nationwide Population-based Study of Korea

Published: 24 November 2022| Version 1 | DOI: 10.17632/rfnfcrzvs8.1
Contributors:
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, Ji Hae Lee,
, Jung Min Bae,

Description

Supplemental Table 1. International Statistical Classification of Diseases, tenth revision (ICD-10) codes of the included diseases Supplemental Table 2. Demographic and health characteristics of COVID-19 and contemporary controls before and after weighting Supplemental Table 3. Demographic and health characteristics of COVID-19 and historical controls before and after weighting Supplemental Figure 1. Covariate balance after application of inverse probability weighting Supplemental Figure 2. Positive and negative outcomes Supplemental Figure 3. Sensitivity analyses: risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the contemporary control cohort. Supplemental Figure 4. Sensitivity analyses: risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the historical control cohort. Supplemental Figure 5. Sensitivity analyses: subgroup analyses of the risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the contemporary control cohort. Supplemental Figure 6. Sensitivity analyses: subgroup analyses of the risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the historical control cohort.

Files

Institutions

Catholic University of Korea School of Medicine, Catholic University of Korea Saint Vincent's Hospital, Yonsei University Wonju College of Medicine

Categories

Dermatology, Autoimmune Disorder, Risk, COVID-19

Funding

National Research Foundation

2017R1A5A2015369

Licence